Arrowhead Research | ARWR - Revenu Net

Prix De L'Action
56.33
Variation Quotidienne
-0.63 -1.11%
Mensuellement
-10.79%
Annuel
280.61%
Q1 Prévisions
54.64




Revenu Net Changement Date
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Novartis USD 2.41B 1.52B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xencor USD -6.65M 626K 2025-12